Literature DB >> 17688285

Differential osteogenic activity of osteoprogenitor cells on HA and TCP/HA scaffold of tissue engineered bone.

Angela M H Ng1, K K Tan, M Y Phang, O Aziyati, G H Tan, M R Isa, B S Aminuddin, M Naseem, O Fauziah, B H I Ruszymah.   

Abstract

Biomaterial, an essential component of tissue engineering, serves as a scaffold for cell attachment, proliferation, and differentiation; provides the three dimensional (3D) structure and, in some applications, the mechanical strength required for the engineered tissue. Both synthetic and naturally occurring calcium phosphate based biomaterial have been used as bone fillers or bone extenders in orthopedic and reconstructive surgeries. This study aims to evaluate two popular calcium phosphate based biomaterial i.e., hydroxyapatite (HA) and tricalcium phosphate/hydroxyapatite (TCP/HA) granules as scaffold materials in bone tissue engineering. In our strategy for constructing tissue engineered bone, human osteoprogenitor cells derived from periosteum were incorporated with human plasma-derived fibrin and seeded onto HA or TCP/HA forming 3D tissue constructs and further maintained in osteogenic medium for 4 weeks to induce osteogenic differentiation. Constructs were subsequently implanted intramuscularly in nude mice for 8 weeks after which mice were euthanized and constructs harvested for evaluation. The differential cell response to the biomaterial (HA or TCP/HA) adopted as scaffold was illustrated by the histology of undecalcified constructs and evaluation using SEM and TEM. Both HA and TCP/HA constructs showed evidence of cell proliferation, calcium deposition, and collagen bundle formation albeit lesser in the former. Our findings demonstrated that TCP/HA is superior between the two in early bone formation and hence is the scaffold material of choice in bone tissue engineering. Copyright 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17688285     DOI: 10.1002/jbm.a.31324

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  15 in total

1.  Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.

Authors:  Elena Veronesi; Alba Murgia; Anna Caselli; Giulia Grisendi; Maria Serena Piccinno; Valeria Rasini; Rosaria Giordano; Tiziana Montemurro; Philippe Bourin; Luc Sensebé; Markus T Rojewski; Hubert Schrezenmeier; Pierre Layrolle; Maria Pau Ginebra; Carmen Bunu Panaitescu; Enrique Gómez-Barrena; Fabio Catani; Paolo Paolucci; Jorge S Burns; Massimo Dominici
Journal:  Tissue Eng Part C Methods       Date:  2013-08-20       Impact factor: 3.056

2.  Biomechanical evaluation of porous bioactive ceramics after implantation: micro CT-based three-dimensional finite element analysis.

Authors:  Li-Mei Ren; Takaaki Arahira; Mitsugu Todo; Hideki Yoshikawa; Akira Myoui
Journal:  J Mater Sci Mater Med       Date:  2011-11-23       Impact factor: 3.896

3.  Biocompatibility of individually designed scaffolds with human periosteum for use in tissue engineering.

Authors:  Stephan T Becker; Timothy Douglas; Yahya Acil; Hermann Seitz; Sureshan Sivananthan; Jörg Wiltfang; Patrick H Warnke
Journal:  J Mater Sci Mater Med       Date:  2010-02-07       Impact factor: 3.896

4.  Bone substitutes and implantation depths for subchondral bone repair in osteochondral defects of porcine knee joints.

Authors:  Tomohiko Matsuo; Keisuke Kita; Tatsuo Mae; Yasukazu Yonetani; Satoshi Miyamoto; Hideki Yoshikawa; Ken Nakata
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-01       Impact factor: 4.342

5.  Radially and axially graded multizonal bone graft substitutes targeting critical-sized bone defects from polycaprolactone/hydroxyapatite/tricalcium phosphate.

Authors:  Asli Ergun; Xiaojun Yu; Antonio Valdevit; Arthur Ritter; Dilhan M Kalyon
Journal:  Tissue Eng Part A       Date:  2012-09-14       Impact factor: 3.845

6.  Effect of Bone Morphogenetic Protein-2 (BMP-2)/Hydroxyapatite/In Situ-Formed Hyaluronan Hydrogel Composites on Bone Formation in a Murine Model of Posterolateral Lumbar Fusion.

Authors:  Akiyoshi Kuroda; Wataru Saito; Gen Inoue; Masayuki Miyagi; Shintaro Shoji; Hiroyuki Sekiguchi; Masashi Takaso; Kentaro Uchida
Journal:  Cureus       Date:  2022-05-30

Review 7.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

8.  Tricalcium phosphate/hydroxyapatite (TCP-HA) bone scaffold as potential candidate for the formation of tissue engineered bone.

Authors:  Shamsul Bin Sulaiman; Tan Kok Keong; Chen Hui Cheng; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Indian J Med Res       Date:  2013-06       Impact factor: 2.375

9.  Repair of segmental load-bearing bone defect by autologous mesenchymal stem cells and plasma-derived fibrin impregnated ceramic block results in early recovery of limb function.

Authors:  Min Hwei Ng; Suryasmi Duski; Kok Keong Tan; Mohd Reusmaazran Yusof; Kiat Cheong Low; Isa Mohamed Rose; Zahiah Mohamed; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

10.  Incorporation of Fucoidan in β-Tricalcium phosphate-Chitosan scaffold prompts the differentiation of human bone marrow stromal cells into osteogenic lineage.

Authors:  Subramaniam Puvaneswary; Hanumantharao Balaji Raghavendran; Sepehr Talebian; Malliga Raman Murali; Suhaeb A Mahmod; Simmrat Singh; Tunku Kamarul
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.